REQUEST A DEMO
Total
USD $0.00
Search more companies

Avicenna Laboratories Inc Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Avicenna Laboratories Inc Company Public Joint Stock Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Avicenna is a manufacturer of the solid dosage form of drug products. Founded in 2001, the company supplies various oral drug products to domestic and international clients. Business Development, Regulatory Affairs, Sales, Marketing and other administrative and financial functions are conducted through its head office in Tehran. Manufacturing and material management Departments are located in Kaveh Industrial Park, 90 km south of Tehran

Headquarters
Yusefabad, Jahanara Ave, 23 Rd St., No. 8
Tehran; Tehran; Postal Code: 1438933741

Contact Details: Purchase the Avicenna Laboratories Inc Company Public Joint Stock report to view the information.

Website: http://www.avicenna.ir

Basic Information
Total Employees:
Purchase the Avicenna Laboratories Inc Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Avicenna Laboratories Inc Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Avicenna Laboratories Inc Company Public Joint Stock report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
1.08%
Subsidiaries
Arasto Pharmacy Company
Company Performance
Financial values in the chart are available after Avicenna Laboratories Inc Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
44.2%
Total operating revenue
44.19%
Operating profit (EBIT)
23.86%
EBITDA
21.32%
Net Profit (Loss) for the Period
53.66%
Total assets
13.52%
Total equity
39.53%
Operating Profit Margin (ROS)
-4.12%
Net Profit Margin
1.27%
Return on Equity (ROE)
1.28%
Debt to Equity Ratio
-0.34%
Quick Ratio
0.33%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?